Treatment of Lennox-Gastaut Syndrome (LGS)

被引:41
作者
Ferrie, Colin D. [1 ]
Patel, Amit [2 ]
机构
[1] Leeds Gen Infirm, Dept Paediat Neurol, Leeds LS2 9NS, W Yorkshire, England
[2] Eisai Ltd, UK Med Advisor, Hatfield, Herts, England
关键词
Epilepsy; Child; Epileptic encephalopathy; Antiepileptic drug; Management; ADD-ON DRUG; KETOGENIC DIET; REFRACTORY EPILEPSY; OPEN-LABEL; CORPUS CALLOSOTOMY; STATUS EPILEPTICUS; CHILDREN; CHILDHOOD; EFFICACY; LAMOTRIGINE;
D O I
10.1016/j.ejpn.2008.12.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lennox-Gastaut Syndrome (LGS) is a severe form of epilepsy that usually starts in early to mid childhood and is characterized by multiple seizure types, abnormal electroencephalogram with slow spike-and-wave discharges and cognitive problems. Numerous approaches are currently used to treat LGS, including use of conventional antiepileptic drugs (most commonly sodium valproate, lamotrigine and topiramate), other drug interventions (corticosteroids and intravenous immunoglobulin) and nonpharmacologic treatments (ketogenic diet, corpus callosotomy and vagus nerve stimulation). Rufinamide is the most recent antiepileptic drug to have shown efficacy in the treatment of LGS. Despite the variety of therapeutic options, there have been only five double-blind, placebo-controlled clinical trials of antiepileptic drugs in LGS and none of these were head-to-head comparison trials. The evidence supporting the use of available treatments for LGS is, therefore, not robust. Here, we review the evidence supporting the use of specific therapies in LGS and provide recommendations on how to set appropriate treatment goals, select treatments and minimize polypharmacy. A suggested treatment algorithm is presented and discussed. Sodium valproate is recommended for first-line therapy; if seizures persist, alternative interventions should be trialed on an individually tailored basis. (C) 2009 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:493 / 504
页数:12
相关论文
共 87 条
[81]   Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold [J].
White, HS ;
Brown, SD ;
Woodhead, JH ;
Skeen, GA ;
Wolf, HH .
EPILEPSY RESEARCH, 1997, 28 (03) :167-179
[82]   Corpus callosotomy in children [J].
Wong, Tai-Tong ;
Kwan, Shang-Yeong ;
Chang, Kai-Ping ;
Wu Hsiu-Mei ;
Yang, Tsui-Fen ;
Chen, Ying-Sheue ;
Yi-Yen, Lee .
CHILDS NERVOUS SYSTEM, 2006, 22 (08) :999-1011
[84]  
Yamatogi Y, 1979, Brain Dev, V1, P267
[85]   Efficacy of zonisamide: our experience [J].
Yamauchi, T ;
Aikawa, H .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2004, 13 :S41-S48
[86]  
Yamauchi T, 2004, SEIZURE S1, V13, pS49
[87]  
2007, BRIT NATL FORMULARY, V53